154 related articles for article (PubMed ID: 10998124)
1. Dopamine control of striatal gene expression during development: relevance to knockout mice for the dopamine transporter.
Fauchey V; Jaber M; Bloch B; Le Moine C
Eur J Neurosci; 2000 Sep; 12(9):3415-25. PubMed ID: 10998124
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
[TBL] [Abstract][Full Text] [Related]
3. Late direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.
Wong JY; Padungchaichot P; Massalas JS; Drago J
Neuroscience; 2000; 95(4):1035-41. PubMed ID: 10682710
[TBL] [Abstract][Full Text] [Related]
4. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
Jung AB; Bennett JP
Brain Res Dev Brain Res; 1996 Jul; 94(2):109-20. PubMed ID: 8836569
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical changes in dopamine D1, D3 and D1/D3 receptor knockout mice.
Wong JY; Clifford JJ; Massalas JS; Finkelstein DI; Horne MK; Waddington JL; Drago J
Eur J Pharmacol; 2003 Jul; 472(1-2):39-47. PubMed ID: 12860471
[TBL] [Abstract][Full Text] [Related]
6. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
Gross CE; Ravenscroft P; Dovero S; Jaber M; Bioulac B; Bezard E
J Neurochem; 2003 Mar; 84(6):1246-55. PubMed ID: 12614325
[TBL] [Abstract][Full Text] [Related]
7. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
Haber SN; Ryoo H; Cox C; Lu W
J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
[TBL] [Abstract][Full Text] [Related]
8. Cellular distribution of adenosine A2A receptor mRNA in the primate striatum.
Svenningsson P; Le Moine C; Aubert I; Burbaud P; Fredholm BB; Bloch B
J Comp Neurol; 1998 Sep; 399(2):229-40. PubMed ID: 9721905
[TBL] [Abstract][Full Text] [Related]
9. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
Aubert I; Ghorayeb I; Normand E; Bloch B
J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
[TBL] [Abstract][Full Text] [Related]
10. Expression of BDNF and trkB mRNAs in comparison to dopamine D1 and D2 receptor mRNAs and tyrosine hydroxylase-immunoreactivity in nigrostriatal in oculo co-grafts.
Strömberg I; Humpel C
Brain Res Dev Brain Res; 1995 Feb; 84(2):215-24. PubMed ID: 7743642
[TBL] [Abstract][Full Text] [Related]
11. Prenatal ontogeny of D2 dopamine receptor and dopamine transporter gene expression in the rat mesencephalon.
Tison F; Normand E; Bloch B
Neurosci Lett; 1994 Jan; 166(1):48-50. PubMed ID: 7910679
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
Jaber M; Dumartin B; Sagné C; Haycock JW; Roubert C; Giros B; Bloch B; Caron MG
Eur J Neurosci; 1999 Oct; 11(10):3499-511. PubMed ID: 10564358
[TBL] [Abstract][Full Text] [Related]
13. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young WS; Bonner TI; Brann MR
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9827-31. PubMed ID: 2432603
[TBL] [Abstract][Full Text] [Related]
14. Effects of in utero cocaine exposure on the expression of mRNAS encoding the dopamine transporter and the D1, D2 and D5 dopamine receptor subtypes in fetal rhesus monkey.
Choi WS; Rønnekleiv OK
Brain Res Dev Brain Res; 1996 Oct; 96(1-2):249-60. PubMed ID: 8922687
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats.
Wang JQ; McGinty JF
Neuroscience; 1996 Nov; 75(1):43-56. PubMed ID: 8923522
[TBL] [Abstract][Full Text] [Related]
16. Early direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.
Padungchaichot P; Wong JY; Natoli AL; Massalas JS; Finkelstein DI; Lawrence AL; Drago J
Neuroscience; 2000; 95(4):1025-33. PubMed ID: 10682709
[TBL] [Abstract][Full Text] [Related]
17. Adaptive gene expression changes on the healthy side of parkinsonian rats.
Capper-Loup C; Frey CM; Rebell D; Kaelin-Lang A
Neuroscience; 2013 Mar; 233():157-65. PubMed ID: 23270858
[TBL] [Abstract][Full Text] [Related]
18. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
Gerfen CR; McGinty JF; Young WS
J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of the proenkephalin system in the rat corpus striatum: its relationship to dopaminergic innervation and transient compartmental expression.
Song DD; Harlan RE
Neuroscience; 1993 Feb; 52(4):883-909. PubMed ID: 8095712
[TBL] [Abstract][Full Text] [Related]
20. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.
Hervé D; Le Moine C; Corvol JC; Belluscio L; Ledent C; Fienberg AA; Jaber M; Studler JM; Girault JA
J Neurosci; 2001 Jun; 21(12):4390-9. PubMed ID: 11404425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]